Home Cart 0 Sign in  
X

[ CAS No. 367-31-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 367-31-7
Chemical Structure| 367-31-7
Chemical Structure| 367-31-7
Structure of 367-31-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 367-31-7 ]

Related Doc. of [ 367-31-7 ]

Alternatived Products of [ 367-31-7 ]

Product Details of [ 367-31-7 ]

CAS No. :367-31-7 MDL No. :MFCD00042228
Formula : C6H7FN2 Boiling Point : -
Linear Structure Formula :- InChI Key :KWEWNOOZQVJONF-UHFFFAOYSA-N
M.W : 126.13 Pubchem ID :164584
Synonyms :

Calculated chemistry of [ 367-31-7 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 35.21
TPSA : 52.04 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.54 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.0
Log Po/w (XLOGP3) : 0.75
Log Po/w (WLOGP) : 1.43
Log Po/w (MLOGP) : 1.24
Log Po/w (SILICOS-IT) : 0.85
Consensus Log Po/w : 1.05

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.59
Solubility : 3.26 mg/ml ; 0.0258 mol/l
Class : Very soluble
Log S (Ali) : -1.42
Solubility : 4.77 mg/ml ; 0.0378 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.92
Solubility : 1.53 mg/ml ; 0.0121 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 367-31-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 367-31-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 367-31-7 ]
  • Downstream synthetic route of [ 367-31-7 ]

[ 367-31-7 ] Synthesis Path-Upstream   1~37

  • 1
  • [ 64-18-6 ]
  • [ 367-31-7 ]
  • [ 1977-72-6 ]
YieldReaction ConditionsOperation in experiment
19.7 g With hydrogenchloride In water for 1.5 h; Cooling with ice; Reflux Reference Example 1Regioisomer mixture of   1-dimethoxymethyl-5-fluoro-1H-benzimidazole[0298]Under ice cooling, 4 mol/L   hydrochloric acid (200 mL) and   formic acid (38.3 g) were sequentially added to   4-fluoro-1,2-phenylenediamine (21.0 g), and the mixture was heated to reflux for 90 minutes while being stirred. Under ice cooling, the reaction mixture was basified with a 10percent aqueous solution of   sodium hydroxide and extracted with ethyl acetate. The organic layer was washed with saturated brine and then dried over anhydrous sodium sulfate. After distilling off the solvent under reduced pressure, the residue was washed with diisopropyl ether, and 5-fluorobenzimidazole (19.7 g) was obtained.   5-Fluorobenzimidazole (19.7 g) thus obtained was dissolved in toluene (500 mL), and methyl orthoformate (38.7 g) and benzenesulfonic acid monohydrate (1.0 g) were sequentially added thereto. The mixture was heated to reflux for 40 hours while being stirred. After distilling off the solvent and methyl orthoformate under reduced pressure, the residue was diluted with toluene. Diisopropylamine (1 mL) and a saturated aqueous solution of sodium hydrogen carbonate were sequentially added thereto under ice cooling, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine and then dried over anhydrous sodium sulfate. After distilling off the solvent under reduced pressure, the residue was purified by basic silica gel chromatography (20percent to 100percent ethyl acetate/hexane), and thus the title compound (25.2 g) was obtained.
Reference: [1] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223
[2] Synlett, 2001, # 11, p. 1755 - 1758
[3] Yakugaku Zasshi, 1958, vol. 78, p. 108[4] Chem.Abstr., 1958, p. 11013
[5] Journal of the American Chemical Society, 1953, vol. 75, p. 1292
[6] Patent: US2013/65896, 2013, A1, . Location in patent: Paragraph 0298
  • 2
  • [ 367-31-7 ]
  • [ 144-62-7 ]
  • [ 1977-72-6 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 8, p. 1337 - 1342
  • 3
  • [ 367-31-7 ]
  • [ 123-06-8 ]
  • [ 1977-72-6 ]
Reference: [1] Patent: US2004/87601, 2004, A1, . Location in patent: Page 19
[2] Patent: WO2004/69829, 2004, A1, . Location in patent: Page 18
  • 4
  • [ 367-31-7 ]
  • [ 122-51-0 ]
  • [ 1977-72-6 ]
Reference: [1] European Journal of Organic Chemistry, 2011, # 15, p. 2827 - 2835
  • 5
  • [ 124-38-9 ]
  • [ 367-31-7 ]
  • [ 1977-72-6 ]
Reference: [1] Green Chemistry, 2013, vol. 15, # 1, p. 95 - 99
[2] New Journal of Chemistry, 2018, vol. 42, # 19, p. 15847 - 15851
  • 6
  • [ 367-31-7 ]
  • [ 68-12-2 ]
  • [ 1977-72-6 ]
Reference: [1] New Journal of Chemistry, 2016, vol. 40, # 10, p. 8282 - 8287
  • 7
  • [ 57-55-6 ]
  • [ 367-31-7 ]
  • [ 118469-15-1 ]
  • [ 1977-72-6 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2010, vol. 83, # 7, p. 831 - 837
  • 8
  • [ 367-31-7 ]
  • [ 107-21-1 ]
  • [ 51-17-2 ]
  • [ 1977-72-6 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2010, vol. 83, # 7, p. 831 - 837
  • 9
  • [ 124-38-9 ]
  • [ 367-31-7 ]
  • [ 1544-75-8 ]
YieldReaction ConditionsOperation in experiment
87 %Chromat. With tetrabutylammonium tungstate In 1-methyl-pyrrolidin-2-one at 140℃; for 24 h; Schlenk technique General procedure: A typical procedure for the I-catalyzed reaction of aryl diamines with 1 atm CO2 was as follows: diamine (1 mmol), I (0.15 mmol), and N-methylpyrrolidone (NMP) (1 mL) were charged in a Schlenk tube with a magnetic stir bar. CO2 (1 atm) was introduced by a balloon, and the reaction mixture was stirred at 140 °C for 24 h. The reaction solution was periodically analyzed by GC, LC, GC–MS, or NMR. A Teflon vessel placed in a stainless steel autoclave was used for reactions with CO2 at 20 atm.
Reference: [1] Angewandte Chemie - International Edition, 2012, vol. 51, # 27, p. 6700 - 6703
[2] Chemistry - An Asian Journal, 2016, vol. 11, # 19, p. 2735 - 2740
[3] ACS Catalysis, 2013, vol. 3, # 9, p. 2076 - 2082
[4] Catalysis Today, 2014, vol. 226, p. 160 - 166
  • 10
  • [ 367-31-7 ]
  • [ 530-62-1 ]
  • [ 1544-75-8 ]
YieldReaction ConditionsOperation in experiment
88% at 20℃; Inert atmosphere; Cooling with ice A stirred solution of 4-fluorobenzene-1 ,2-diamine (15.1 g, 120 mmol) in THF (120 mL) under nitrogen was cooled using an ice-bath and then was treated with di(1 -/-imidazol-1 - yl)methanone (23.4 g, 144 mmol) portion-wise over 15 min. The resulting mixture was slowly warmed to room temperature then was concentrated in vacuo after 2.5 h. The residue was suspended in a mixture of water and DCM (250 mL each) and filtered off. This residue was then washed with water (50 mL) and DCM (50 mL), before being dried at 40 °C under vacuum for 16 h to give the title compound (16.0 g, 105 mmol, 88percent) as a brown solid. LCMS (high pH): Rt 0.57 min; [M-H+]" = 151.1 δΗ NMR (400 MHz, DMSO-d6) ppm 10.73 (br s, 1 H), 10.61 (br s, 1 H), 6.91-6.84 (m, 1 H), 6.78-6.70 (m, 2H).
78% at 150℃; for 0.333333 h; Microwave irradiation Intermediate 15: 5-Fluoro-1 ,3-dihvdro-2H-benzimidazol-2-one; A mixture of 4-fluoro-1 ,2-diaminobenzene (commercially available, 1.0 g, 7.9 mmol), carbonyldiimidazole (1.4 g) and THF (4 ml) was heated to 150 0C in a microwave reactor and stirred for 10 minutes. The mixture was heated to 150 0C and stirred for a further 10 <n="38"/>minutes. The mixture was cooled to room temperature and concentrated under vacuum. The residue was suspended in dilute hydrochloric acid and filtered. The filter-cake was washed with water and cyclohexane then dried under vacuum to give the title compound as a dark grey solid (0.95 g, 78percent). 1 H-NMR (400 MHz, DMSO-d6): δ 10.73 (1 H, br s), 10.62 (1 H, br s), 6.87 (1 H, dd, J 8.5, 5 Hz), 6.78-6.70 (2H, m). UPLC-MS: 0.47 min, m/z 153 [M+H]+.
52% at 20℃; a) 4-Fluorobenzene-1,2-diamine (2 g, 15.86 mmol) was dissolved in THF (49.4 ml) and 1,1'-Carbonyldiimidazole (2.83 g, 17.44 mmol) was added at RT. The reaction mixture was stirred overnight at RT. To this was added concentrated ammonia solution (1.5 ml) and the mixture stirred for 30 minutes and then diluted with water (100 ml). The resultant solid was collected by filtration, washed with water, followed by Et2O and then dried in vacuo to afford 5-fluoro-1H-benzo[d]imidazol-2(3H)-one (1.250 g, 52percent); 1H NMR (400 MHz, DMSO-d6) 6.66-6.79 (2H, m), 6.81-6.94 (1H, m), 10.64 (1H, s), 10.76 (1H, s); m/z: (ES+) MH+, 151.19.
Reference: [1] Patent: WO2016/62737, 2016, A1, . Location in patent: Page/Page column 24
[2] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 6, p. 552 - 557
[3] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 11, p. 1190 - 1195
[4] Journal of Medicinal Chemistry, 2006, vol. 49, # 12, p. 3719 - 3742
[5] Patent: WO2008/129007, 2008, A1, . Location in patent: Page/Page column 36-37
[6] Patent: US2011/306613, 2011, A1, . Location in patent: Page/Page column 37
  • 11
  • [ 367-31-7 ]
  • [ 503-38-8 ]
  • [ 1544-75-8 ]
YieldReaction ConditionsOperation in experiment
93% With triethylamine In dichloromethane at 0 - 20℃; for 2 h; [0278] To a solution of 4-fluorobenzene-1,2-diamine lb (1.39 g, 11.0 mmol) and triethylamine (3.26 mE, 23.2 mmol) in methylene chloride (20 mE) was added dropwise a solution of diphosgene (0.69 mE, 5.72 mmol) in methylene chloride (5 mE) at 0 to 5° C. The resulting suspension was stirred for 2 hours at room temperature and filtered. The collected white solid was washed with water and dried to give compound 2b (1.56 g, 93percent). ‘H NMR (400 MHz, DMSO-d5) ö 10.73 (s, 1H), 10.61 (s, 1H), 6.97-6.81 (m, 1H), 6.74 (m, 2H); MS (ESI): mlz 153.1 [M+1]
Reference: [1] Patent: US2017/290830, 2017, A1, . Location in patent: Paragraph 0277; 0278
  • 12
  • [ 1202680-24-7 ]
  • [ 367-31-7 ]
  • [ 1544-75-8 ]
YieldReaction ConditionsOperation in experiment
70% for 29 h; Reflux; Green chemistry General procedure: A mixture of 2-phenoxycarbonyl-4,5-dichloropyridazin-3(2H)-one (2a, 1.2 equiv), compounds 4 (1 equiv), and toluene (10 mL)was stirred at reflux conditions until amide intermediate wasconsumed (monitored by TLC). After cooling to r.t., the resultingprecipitate was filtered off and the solvent was evaporatedunder reduced pressure. The residue was transferred to anopen-bed silica gel column (3 × 7 cm). The column was elutedwith n-hexane–THF (1:2, v/v). Fractions containing compounds5 were combined and evaporated under reduced pressure togive compounds 5.
Reference: [1] Synlett, 2015, vol. 26, # 14, p. 1985 - 1990
  • 13
  • [ 75-44-5 ]
  • [ 367-31-7 ]
  • [ 1544-75-8 ]
Reference: [1] Journal of the American Chemical Society, 1958, vol. 80, p. 1662
  • 14
  • [ 79-14-1 ]
  • [ 367-31-7 ]
  • [ 39811-07-9 ]
Reference: [1] Molecules, 2015, vol. 20, # 8, p. 15206 - 15223
[2] MedChemComm, 2018, vol. 9, # 7, p. 1194 - 1205
  • 15
  • [ 924-44-7 ]
  • [ 367-31-7 ]
  • [ 145323-53-1 ]
  • [ 55687-23-5 ]
Reference: [1] Patent: WO2014/114776, 2014, A1, . Location in patent: Page/Page column 24
[2] Patent: US9527885, 2016, B2, . Location in patent: Page/Page column 615
[3] Patent: WO2006/134378, 2006, A1, . Location in patent: Page/Page column 131
  • 16
  • [ 924-44-7 ]
  • [ 367-31-7 ]
  • [ 55687-23-5 ]
Reference: [1] Journal of Organic Chemistry, 2017, vol. 82, # 19, p. 10077 - 10091
  • 17
  • [ 924-44-7 ]
  • [ 367-31-7 ]
  • [ 1233932-59-6 ]
  • [ 55687-33-7 ]
Reference: [1] Patent: US9527885, 2016, B2, . Location in patent: Page/Page column 615; 616
  • 18
  • [ 2369-11-1 ]
  • [ 367-31-7 ]
YieldReaction ConditionsOperation in experiment
90% With hydrogen In methanol at 20℃; for 2 h; A solution of 5-fluoro-2-nitroaniline in MeOH (0.32 M) was added to Pd/C (5percentw/w, 10percentw). The reaction mixture was stirred at R.T.under H2 atmosphere (50 Psi) for 2 h. Then, the mixture was filtrated and the organic solution was concentrated to afford (90percent) the title compound as a brown oil. MS (ES+) C6H7FN2 required: 126, found: 127 (M+H)+.
76% at 80℃; for 8 h; General procedure: Nitro aromatic (1.0 mmol), B2(OH)4 (5.0 equiv, 5.0 mmol), and H2O (3.0 mL) were added in a10 mL tube. The reaction mixture was stirred at 80 °C for 8 h. When the reaction was completemonitored by TLC, the mixture was cooled to room temperature, extracted with ethyl acetate (3 ×20 mL). The combined organic phase was dried over anhydrous Na2SO4, filtered, andconcentrated under reduced pressure. The residue was purified by silica gel columnchromatography.
68% With tetrahydroxydiboron; 5%-palladium/activated carbon; water In acetonitrile at 50℃; for 24 h; General procedure: Nitrobenzene (0.6mmol), 5wtpercent Pd/C (0.5mmol percent, 0.003mmol), H2O (10 equiv, 6.0mmol), B2(OH)4 (3.3 equiv, 2.0mmol), and CH3CN (1.0mL) were added in a 10mL tube. The reaction mixture was stirred at 50°C for 24h. When the reaction was complete monitored by TLC, the mixture was cooled to room temperature. Water (5mL) was added, and extracted with EtOAc (3×5mL). The combined organic phase was dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give aniline 2a (55mg, 99percent).
Reference: [1] Macromolecules, 2005, vol. 38, # 2, p. 297 - 306
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1994, # 19, p. 2751 - 2758
[3] Patent: WO2010/13037, 2010, A1, . Location in patent: Page/Page column 67
[4] Synlett, 2018, vol. 29, # 13, p. 1765 - 1768
[5] Tetrahedron, 2017, vol. 73, # 27-28, p. 3898 - 3904
[6] Patent: WO2008/75109, 2008, A1, . Location in patent: Page/Page column 102
[7] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 1156 - 1159
[8] Chemistry--A European Journal, 2012, vol. 18, # 36, p. 11433 - 11439,7
[9] Chemistry - A European Journal, 2012, vol. 18, # 36, p. 11433 - 11439
[10] Journal of Medicinal Chemistry, 2017, vol. 60, # 14, p. 6289 - 6304
  • 19
  • [ 364-78-3 ]
  • [ 367-31-7 ]
YieldReaction ConditionsOperation in experiment
88% With hydrogen In methanol at 20℃; for 4 h; 4-fluoro-2-nitroaniline (8.00 g, 51.22 mmol) was dissolved in methanol (100 mL), and 10percent palladium-carbon powder (0.80 g) was added thereto, followed by stirring for four hours at room temperature under hydrogen atmosphere.
The reaction mixture was filtrated, and the filtrate was concentrated under reduced pressure.
The residue was purified column chromatography (silica gel 150 g, hexane ethyl acetate=1:4), to thereby yield a brown oil (5.67 g, yield 88percent).
The brown oil (5.64 g, 44.72 mmol) was dissolved in ethanol (150 mL), and potassium o-ethylxanthate (8.60 g, 53.65 mmol) was added thereto, followed by reflux for three hours.
Potassium o-ethylxanthate (1.43 g, 8.92 mmol) was further added thereto, and the mixture was refluxed for two hours.
The reaction mixture was concentrated under reduced pressure, and the residue was purified through column chromatography (silica gel 150 g, hexane:ethyl acetate=2:1), to thereby yield 5-fluoro-2-mercaptobenzimidazole (5.93 g, yield 79percent) as a brown powder.
70% With hydrogenchloride; tin In water at 20℃; for 1 h; When 5-fluoro-2-nitroaniline (4.496 g, 0.0288 mol) was dissolved in 150 ml of concentrated hydrochloric acid I turned it on. A small amount of tin (16.56 g, 0.140 mol) was added over 15 minutes at 0 . Room temperature Temperature), the mixture was stirred for 1 hour and then cooled overnight. Deionized water The mixture was poured into water and 4M sodium hydroxide (NaOH) was slowly added until pH 10 was reached. The organic layer was washed with Extracted with ethyl acetate (4 x 100 mL), washed with water (4 x 100 mL), dried over anhydrous magnesium sulfate 4). The solution was concentrated in vacuo to give 2.54 g of yellow
Reference: [1] Macromolecules, 2005, vol. 38, # 2, p. 297 - 306
[2] Farmaco, Edizione Scientifica, 1986, vol. 41, # 12, p. 970 - 983
[3] Patent: US2005/20606, 2005, A1, . Location in patent: Page 10
[4] Heterocycles, 1987, vol. 26, # 9, p. 2433 - 2442
[5] Organic Preparations and Procedures International, 2000, vol. 32, # 5, p. 485 - 488
[6] Patent: KR2017/50088, 2017, A, . Location in patent: Paragraph 0192; 0193; 0194; 0195
[7] Journal of the Chemical Society, 1953, p. 3042
[8] Yakugaku Zasshi, 1958, vol. 78, p. 108[9] Chem.Abstr., 1958, p. 11013
[10] Journal of the American Chemical Society, 1953, vol. 75, p. 1292
[11] Journal of Fluorine Chemistry, 1990, vol. 46, # 2, p. 343 - 355
[12] Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1985, vol. 39, # 1, p. 31 - 34
[13] Journal de Chimie Physique et de Physico-Chimie Biologique, 1986, vol. 83, # 9, p. 577 - 588
[14] Journal of Medicinal Chemistry, 1995, vol. 38, # 25, p. 4906 - 4916
[15] Bioorganic and Medicinal Chemistry, 1998, vol. 6, # 2, p. 163 - 172
[16] Farmaco, 1998, vol. 53, # 7, p. 455 - 461
[17] Farmaco (Societa chimica italiana : 1989), 2001, vol. 56, # 11, p. 821 - 826
[18] European Journal of Medicinal Chemistry, 2006, vol. 41, # 1, p. 135 - 141
[19] Journal of the American Chemical Society, 2006, vol. 128, # 26, p. 8569 - 8574
[20] Molecules, 2006, vol. 11, # 12, p. 988 - 999
[21] Patent: US6632813, 2003, B1, . Location in patent: Page/Page column 37
[22] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 17, p. 4790 - 4793
[23] Journal of the Serbian Chemical Society, 2014, vol. 79, # 3, p. 277 - 282
[24] Patent: WO2014/114776, 2014, A1, . Location in patent: Page/Page column 24
[25] Molecules, 2014, vol. 19, # 7, p. 9736 - 9759
[26] Tetrahedron Letters, 2015, vol. 56, # 48, p. 6762 - 6767
  • 20
  • [ 364-78-3 ]
  • [ 7732-18-5 ]
  • [ 367-31-7 ]
Reference: [1] Patent: US5514680, 1996, A,
  • 21
  • [ 351-83-7 ]
  • [ 367-31-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 25, p. 4906 - 4916
[2] Journal of Fluorine Chemistry, 1990, vol. 46, # 2, p. 343 - 355
  • 22
  • [ 448-39-5 ]
  • [ 367-31-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 25, p. 4906 - 4916
[2] Journal of Fluorine Chemistry, 1990, vol. 46, # 2, p. 343 - 355
  • 23
  • [ 371-40-4 ]
  • [ 367-31-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 25, p. 4906 - 4916
  • 24
  • [ 446-35-5 ]
  • [ 367-31-7 ]
Reference: [1] Macromolecules, 2005, vol. 38, # 2, p. 297 - 306
  • 25
  • [ 75-15-0 ]
  • [ 367-31-7 ]
  • [ 583-42-6 ]
YieldReaction ConditionsOperation in experiment
98.2% at 20℃; for 86.833 h; (52a)
5-fluoro-1H-benzimidazole-2-thiol
A mixture of 3,4-diamino-1-fluorobenzene (10 g, 79.3 mmol), carbon disulfide (70 ml, 1164 mmol), and methanol (100 ml) was stirred at room temperature for 86 hours and 50 minutes.
After the reaction mixture was concentrated, the residue was suspended in hexane.
The resultant precipitate was collected by filtration and washed with hexane to obtain the title compound (13.1 g, yield: 98.2percent) as a brown solid.
1H NMR(400 MHz, DMSO-d6) δppm; 6.90-6.99(2H, m), 7.06-7.13(1H, m), 12.58(1H, s), 12.61(1H, s).
Reference: [1] Patent: US2007/10542, 2007, A1, . Location in patent: Page/Page column 76
  • 26
  • [ 367-31-7 ]
  • [ 140-89-6 ]
  • [ 583-42-6 ]
YieldReaction ConditionsOperation in experiment
79% for 5 h; Heating / reflux 4-fluoro-2-nitroaniline (8.00 g, 51.22 mmol) was dissolved in methanol (100 mL), and 10percent palladium-carbon powder (0.80 g) was added thereto, followed by stirring for four hours at room temperature under hydrogen atmosphere.
The reaction mixture was filtrated, and the filtrate was concentrated under reduced pressure.
The residue was purified column chromatography (silica gel 150 g, hexane ethyl acetate=1:4), to thereby yield a brown oil (5.67 g, yield 88percent).
The brown oil (5.64 g, 44.72 mmol) was dissolved in ethanol (150 mL), and potassium o-ethylxanthate (8.60 g, 53.65 mmol) was added thereto, followed by reflux for three hours.
Potassium o-ethylxanthate (1.43 g, 8.92 mmol) was further added thereto, and the mixture was refluxed for two hours.
The reaction mixture was concentrated under reduced pressure, and the residue was purified through column chromatography (silica gel 150 g, hexane:ethyl acetate=2:1), to thereby yield 5-fluoro-2-mercaptobenzimidazole (5.93 g, yield 79percent) as a brown powder.
Reference: [1] Patent: US2005/20606, 2005, A1, . Location in patent: Page 10
[2] Chemical and Pharmaceutical Bulletin, 1989, vol. 37, # 6, p. 1517 - 1523
[3] Journal of Medicinal Chemistry, 1995, vol. 38, # 25, p. 4906 - 4916
  • 27
  • [ 367-31-7 ]
  • [ 113269-06-0 ]
Reference: [1] Heterocycles, 1987, vol. 26, # 9, p. 2433 - 2442
  • 28
  • [ 367-31-7 ]
  • [ 140-89-6 ]
  • [ 80087-71-4 ]
Reference: [1] Patent: WO2010/57121, 2010, A1, . Location in patent: Page/Page column 97
  • 29
  • [ 367-31-7 ]
  • [ 123-54-6 ]
  • [ 118469-15-1 ]
Reference: [1] Patent: WO2008/137027, 2008, A2, . Location in patent: Page/Page column 81-82
  • 30
  • [ 1445-45-0 ]
  • [ 367-31-7 ]
  • [ 118469-15-1 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 11, p. 4287 - 4299
[2] Patent: WO2017/222951, 2017, A1, . Location in patent: Page/Page column 84
  • 31
  • [ 367-31-7 ]
  • [ 2208-07-3 ]
  • [ 118469-15-1 ]
Reference: [1] Patent: US5180723, 1993, A,
  • 32
  • [ 141-82-2 ]
  • [ 367-31-7 ]
  • [ 118469-15-1 ]
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 8, p. 1337 - 1342
  • 33
  • [ 57-55-6 ]
  • [ 367-31-7 ]
  • [ 118469-15-1 ]
  • [ 1977-72-6 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2010, vol. 83, # 7, p. 831 - 837
  • 34
  • [ 64-17-5 ]
  • [ 367-31-7 ]
  • [ 615-15-6 ]
  • [ 118469-15-1 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2010, vol. 83, # 7, p. 831 - 837
  • 35
  • [ 367-31-7 ]
  • [ 64-19-7 ]
  • [ 118469-15-1 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 24, p. 8267 - 8276
  • 36
  • [ 24424-99-5 ]
  • [ 367-31-7 ]
  • [ 579474-47-8 ]
YieldReaction ConditionsOperation in experiment
69% at 0 - 20℃; for 0.0833333 h; Step 1. To 4-fluorobenzene-1,2-diamine (13.88 g, 110.04 mmol) was added ditert-butyldicarbonate (50 mL) at 0°C. The resulting mixture was stirred at ambient temperature for 5 mm, then diluted with ice-water (500 mL) and extracted with 1:1 ethyl acetate-hexane (500 mL). The organic phase was washed with brine (300 mL), dried over Mg504, then filtered and the remaining liquid evaporated. The residual solid was washedwith hexane to afford tert-butyl (2-amino-4-fluorophenyl)carbamate (17.0 g, 69percent yield). 1H NMR (500 MHz, Acetone-d6) ö 7.48 (br. s, 1H), 7.05 - 7.26 (m, 1H), 6.51 - 6.59 (m, 1H), 6.27 - 6.38 (m, 1H), 4.80 (s, 2H), 1.47 (s, 9H).
44% at 20℃; for 6 h; Tert-butyl 2-amino-4-fluorophenylcarbamate (Compound 0113-60) A solution of 4-fluorobenzene-l,2-diamine (0.252 g, 2.0 mmol), (BoC)2O(0.436 g, 2.0 mmol) in dry THF (6 mL) was stirring at room temperature for 6 h. The reaction mixture was concentrated in vacuo, extracted with ethyl acetate. The organic phase was washed with saturated NaHCO3, dried over anhydrous Na2SO4, evaporated to afford crude product as oil. The product was further purified by flash column chromatography on silica gel (ethyl acetate in petroleum ether, 20percent v/v) to afford pure product 0113-60 (0.2 g, 44 percent) as a yellow solid. LCMS: 171 [M-56+l]+, 1H-NMR (400 MHz. DMSO-J6) "5 1.51 (s, 9H), 5.20 (s, 2H), 6.35 (m, IH), 6.52 (dd, J= 11.2, 2.8 Hz, IH), 7.17 (m, IH), 8.32 (s, IH).
Reference: [1] Patent: WO2015/30847, 2015, A1, . Location in patent: Page/Page column 134
[2] Patent: WO2010/75542, 2010, A1, . Location in patent: Page/Page column 78
[3] Patent: US2012/94971, 2012, A1, . Location in patent: Page/Page column 42
  • 37
  • [ 924-44-7 ]
  • [ 367-31-7 ]
  • [ 1233932-59-6 ]
  • [ 55687-33-7 ]
Reference: [1] Patent: US9527885, 2016, B2, . Location in patent: Page/Page column 615; 616
Same Skeleton Products
Historical Records

Similar Product of
[ 367-31-7 ]

Chemical Structure| 55495-99-3

A1003675[ 55495-99-3 ]

4-Fluorobenzene-1,2-diamine hydrochloride

Reason: Free-salt

Related Functional Groups of
[ 367-31-7 ]

Fluorinated Building Blocks

Chemical Structure| 2369-29-1

[ 2369-29-1 ]

3,5-Difluorobenzene-1,2-diamine

Similarity: 0.89

Chemical Structure| 18645-88-0

[ 18645-88-0 ]

3-Fluorobenzene-1,2-diamine

Similarity: 0.89

Chemical Structure| 372-39-4

[ 372-39-4 ]

3,5-Difluoroaniline

Similarity: 0.89

Chemical Structure| 153505-39-6

[ 153505-39-6 ]

3,4-Difluorobenzene-1,2-diamine

Similarity: 0.87

Chemical Structure| 6264-67-1

[ 6264-67-1 ]

4-Fluorobenzene-1,3-diamine

Similarity: 0.83

Aryls

Chemical Structure| 2369-29-1

[ 2369-29-1 ]

3,5-Difluorobenzene-1,2-diamine

Similarity: 0.89

Chemical Structure| 18645-88-0

[ 18645-88-0 ]

3-Fluorobenzene-1,2-diamine

Similarity: 0.89

Chemical Structure| 372-39-4

[ 372-39-4 ]

3,5-Difluoroaniline

Similarity: 0.89

Chemical Structure| 153505-39-6

[ 153505-39-6 ]

3,4-Difluorobenzene-1,2-diamine

Similarity: 0.87

Chemical Structure| 6264-67-1

[ 6264-67-1 ]

4-Fluorobenzene-1,3-diamine

Similarity: 0.83

Amines

Chemical Structure| 2369-29-1

[ 2369-29-1 ]

3,5-Difluorobenzene-1,2-diamine

Similarity: 0.89

Chemical Structure| 18645-88-0

[ 18645-88-0 ]

3-Fluorobenzene-1,2-diamine

Similarity: 0.89

Chemical Structure| 372-39-4

[ 372-39-4 ]

3,5-Difluoroaniline

Similarity: 0.89

Chemical Structure| 153505-39-6

[ 153505-39-6 ]

3,4-Difluorobenzene-1,2-diamine

Similarity: 0.87

Chemical Structure| 6264-67-1

[ 6264-67-1 ]

4-Fluorobenzene-1,3-diamine

Similarity: 0.83